The rise in antibiotic-resistant bacteria, including strains that are resistant to last-resort
antibiotics, and the limited ability of antibiotics to eradicate biofilms have necessitated the …

Bacterial infection is one of the top ten leading causes of death globally and the worst killer
in low‐income countries. The overuse of antibiotics leads to ever‐increasing antibiotic …

Antibacterial resistance is a great concern and requires global action. A critical question is
whether enough new antibacterial drugs are being discovered and developed. A review of …

Pseudomonas aeruginosa is an opportunistic pathogen that is a leading cause of morbidity
and mortality in cystic fibrosis patients and immunocompromised individuals. Eradication of …

Bacterial-infections are mostly due to bacteria in an adhering, biofilm-mode of growth and
not due to planktonically growing, suspended-bacteria. Biofilm-bacteria are much more …

Nanoparticles have immense industrial, biotechnological, and biomedical/pharmaceutical
applications due to their pliability in structure, size, biocompatibility, high surface area, and …

Superficial melanoma is the deadliest form of skin cancer without desirable clinically
therapeutic options. Nanozymes, artificial nanomaterials with physicochemical performance …

The rapid emergence of drug resistance continues to outpace the development of new
antibiotics in the treatment of infectious diseases. Conventional therapy is currently limited …

The global challenges presented by drug-resistant bacterial infections have stimulated much
activity in finding new treatments. This review summarizes the progress and setbacks of non …

Silica nanoparticles (SNPs) have shown great applicability potential in a number of fields
like chemical, biomedical, biotechnology, agriculture, environmental remediation and even …